Strong surveillance systems and the absence of sustained global human-to-human transmission for any novel pathogen underpin the 94.5% market-implied odds against a new pandemic declaration in 2026. The WHO-designated PHEIC for the Bundibugyo Ebola outbreak remains regionally contained in the DRC and Uganda, while mpox clade Ib, dengue, chikungunya, and hantavirus clusters show limited geographic spread without exponential growth or reassortment per CDC and WHO monitoring. Post-COVID advances in genomic sequencing and early-warning networks have further reduced escalation risk from zoonotic spillovers. Realistic challenges include undetected viral evolution in reservoirs or rapid international seeding before year-end that could meet pandemic criteria.